Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Home
Lupin Limited
Press Release Jan 31 2023
Business
Jan 31 2023
3 min read

Press Release Jan 31 2023

Lupin Limited has informed the Exchange regarding a press release dated January 31, 2023, titled "Lupin Receives Tentative Approval from U.S. FDA for Dolutegravir, Emtricitabineand Tenofovir Alafenamide (DETAF) Tablets.".

View Attachment